Femarelle: the safe and effective choice to accompany
Medicinal: 322 mg Fermented soybean extract; Non medicinal: Flaxseed, gelatin
Dosage: Twice a day
Packaging: 56 capsules
Each capsule of Femarelle contains 322 mg of fermented Soybean Extract (DT56a), a plant-based Selective Estrogen Receptor Modulator (SERM) and can be termed a phytoSERM.
A phyto-SERM affects estrogen receptors only in specific sites alleviating menopausal symptoms and promoting bone health, while having no negative effect on the uterus and the breast tissue.
Studies have shown that since Femarelle® acts as a phyto-SERM it is able to target various parts of the body, relieving menopausal symptoms and promoting bone health, while having no effect on the breast and the uterus.
Femarelle® is a new generation of treatment for menopause management that has been approved by Health Canada, and has been on market worldwide since 2000. Currently there are no other products on the market like it.
• Relieves menopausal symptoms:
• Hot flushes, night sweats, sleep disturbances
• Supports bone health
• Is derived from fermented Soy Extract
• Is NOT an estrogen:
• (no estrogenic effects such as stimulation of the uterus and breast tissue)
• Has a good safety profile
• Rare transient side effects
• No serious side effects reported (14 years on the market in other countries)
• 3.5 million months of treatment
What do Studies Say?
Clinical research and experience have shown that relief of menopausal symptoms is felt, on average, within the first month of treatment. Three in four women report relief, with alleviation of hot flushes in 76%, relief of joint and muscle pain in 70%, and relief of headaches in 68% (the main symptoms associated with the menopause transition). These rates were statistically significant (P <0.01).
Your Bone Health is Critically Important too
Once women reach menopause, the decline in estrogen accelerates the process of bone loss to between 2% and 4% a year. This process leads to low bone mass and structural deterioration of bone tissue, resulting in bone fragility and greater susceptibility to fractures, especially of the hip, spine, and wrist. Studies with Femarelle® have shown that patients may experience a positive effect on bone health by increasing the bone mineral density (BMD) in their hip and spine after 12 months of treatment with Femarelle®.
Femarelle® is Unique:
The unique active complex in Femarelle® represents a novel and effective treatment for the relief of menopausal symptoms and to support bone health. Femarelle® is not an estrogen and there are no other chemically similar treatments for human use. The selective mechanism of action of Femarelle® enables it to act as an agonist on the estrogen receptors and thus, to exert a favorable effect on menopausal symptoms (hot flushes and sleep disturbances) and to support bone health while having an antagonistic effect on the estrogen receptors in breast tissue and in the uterus.
Is Femarelle® a Hormone Therapy?
Femarelle® is not an estrogen. The efficacy of Femarelle® was seen to parallel the efficacy of Hormone Therapy, however, due to its selective properties, Femarelle® provides a safe solution for the long-term management of menopause. For all these reasons, Femarelle® is therefore, an appropriate first-line safe and effective therapy for the treatment of menopausal symptoms and to support bone health.
Is Femarelle Safe?
In addition to the proven efficacy, studies also demonstrated the safety of Femarelle®. Since Femarelle® acts selectively it is able to target various parts of the body, relieving menopausal symptoms and promoting bone health, while having no effect on the breast and the uterus. Although new to Canada, Femarelle® has been available in other countries since 2000, and to date there has been over 3.5 million months of therapy used with no reported serious side effects. Reported side effects have been rare and transient.
What are the Quality Control Standards of Femarelle®?
The manufacturing procedure of Femarelle® follows the industry standards for drugs; comprehensive microbiological and biochemical testing are rigorously performed throughout the process. The pharmacological efficacy and the shelf life of the product are constantly monitored, and state-of-the-art technology is used to maintain the long-term stability of the active ingredient in the product.
The manufacturing procedure is subject to the strictest quality control standards with ISO 9001-2008, HAACP, cGMP and BVQI certificates as well as the environmental ISO 14001.
Se-cure Pharmaceuticals Ltd. is committed to ensuring that each capsule produced is characterized by identical therapeutic features according to the accepted standards of the pharmaceutical industry.
Femarelle® should be taken twice a day, one capsule in the morning and one in the evening. You may swallow the capsule with some water. Femarelle® can be taken with or without food. It is important that you take two capsules a day as this is the required dose for optimal benefit. If a dose is missed, a capsule should be taken as soon as you remember, and the regular dose schedule should then continue. There is no need to take a double dose to make up for a missed dose.
"I must say thank you to my boss for recommending me to Femarelle. Since starting to take the product about 6 weeks ago, the intensity of my hot flashes has greatly decreased. Where previously the sweat would be pouring off me, I now get the occasional mild (and I mean mild) warming glow. In addition, my night sweats have all but disappeared. I am now recommending this product to everyone.